Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Hua Medicine ( (HK:2552) ).
Hua Medicine plans to update its constitutional documents by replacing its third amended and restated memorandum and articles of association with a fourth version. The key change is to permit shareholder general meetings to be held as electronic or hybrid meetings and to enable voting by electronic means, alongside related consequential and housekeeping amendments.
The proposed amended articles will require approval by shareholders through a special resolution at the upcoming annual general meeting before taking effect. The company will send a circular detailing the changes and the AGM notice to shareholders in due course, signaling a move toward more flexible and technology-enabled corporate governance arrangements.
More about Hua Medicine
Hua Medicine is a biopharmaceutical company incorporated in the Cayman Islands and listed in Hong Kong under stock code 2552. The company is governed by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical listed-company structure focused on corporate governance and shareholder oversight.
Average Trading Volume: 3,554,772
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$3.74B
See more insights into 2552 stock on TipRanks’ Stock Analysis page.